spacer
home > pmps > winter 2002 > starch based excipients for tabletting
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Starch Based Excipients for Tabletting

Excipients are commonly defined as the additives used to convert pharmacologically active compounds into a pharmaceutical dosage form suitable for administering to patients. They are useful both as diluent of the active drug and processing aid for the formulation. Excipients should be physiologically inert and compatible with active ingredients. They should show no ageing in terms of physical and chemical stability and should be neutral in terms of odour, taste and colour. Many natural carbohydrates and their derivatives meet these requirements and therefore are widely used in the pharmaceutical industry.

Wet and dry granulation are frequently used methods for the manufacturing of tablets. But with the availability of specific developed excipients the pharmaceutical industry has the opportunity to choose a more efficient and economical process: direct compression. The choice of excipient is extremely critical in formulating direct compression tablets. Longstanding suppliers of pharmaceutical excipients, are therefore proactive in the research and development of new forms of excipient that are suitable for direct compression.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Dr Jacques Michaud, Business Manager Pharma & Cosmetics at Cerestar, Belgium
Dr Jacques Michaud obtained a PhD in Organic Chemistry in 1990 from the Universitй Pierre et Marie Curie, Paris VI. Dr Michaud has been working for Cerestar since 1990 where he managed the Application Centre Pharma & Chemical in the R&D centre of Cerestar in Vilvoorde, Belgium. The centre is in charge of developing new applications of starch and starch derivatives for the chemical and the pharmaceutical industries.

Dr Michaud is an expert at the European Pharmacopoeia and represents his company at the IPEC. He has been recently appointed Business Manager, and is responsible for co-ordinating the technical and commercial activities of Cerestar in the pharmaceutical and cosmetics applications.

spacer
Dr Jacques Michaud
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

ERT’s At-Home Cardiac Safety Assessment Ensures Clinical Trial Continuity

PHILADELPHIA – March 30, 2020 – ERT, a global data and technology company that captures critical endpoint data while minimizing uncertainty and risk in clinical trials, today announced a cardiac safety solution that helps biopharmaceutical researchers continue important clinical trials during current global ‘stay home’ mandates. The solution enables clinician-administered ECG readings ─ using ERT’s provisioned, FDA-cleared devices or other investigative site–owned equipment ─ to evaluate the safety of new vaccines and medical treatments from patients’ homes.
More info >>

White Papers

The Key To Tableting Success: How To Choose The Right Tooling

Natoli Engineering Company, Inc.

Choosing the right tooling can increase tablet output, decrease waste and ultimately determine the success of a product launch.
More info >>

 
Industry Events

INTERPHEX 2020

15-17 July 2020, Javits Center NYC


More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement